1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc.

PDMI
Paradigm Medical Industries, Inc.US flagOther OTC
0.00
USD
- -
- -
324,879.00Market Cap
Paradigm Medical Industries, Inc.
PDMI
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
TTM
FRC
311.53
1,319.26
742.86
7,564.78
6,922.88
5,981.12
3,027.64
1,271.93
1,205.51
523.67
125.41
70.71
11.05
0.08
0.02
- -
2
Revenue per Share
-4,361.37
-7,387.86
-4,400
-4,788.46
-8,063.26
-7,898.04
-6,291.6
-1,426.61
3.94
-1,282.18
-103.75
-62.06
-15.17
-0.08
-0.02
- -
-2.48
Basic EPS, GAAP
-4,361.37
-6,860.16
-1,371.43
-3,739.88
-5,231.37
-6,811.93
-1,584.88
-294.8
-187.8
-634.78
-47.31
-42.87
-4.42
-0.04
-0.03
- -
-0.5
Free Cash Flow per Basic Share
311.53
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-12,772.59
-21,899.74
-9,085.71
-20,647.77
-28,028.6
-32,089.12
-30,250.42
-23,614.14
-22,355.12
-14,775.16
-3,645.66
-2,281.53
-545.15
-5.5
-1.33
- -
-104.92
Book Value per Share
12,461.06
1,583.11
971.43
5,668.02
6,353.55
6,429
1,092.5
-1.66
3.54
-440.88
-129.41
-95.8
-35.96
-0.32
-0.06
- -
-6.68
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
11
46
- -
1
Basic Weighted Avg Shares
- -
- -
1
7
8
8
5
3
3
2
2
2
1
1
1
1
1
Sales/Revenue/Turnover
-1,400
-540
-207.69
-63.01
-118.21
-117.25
-207.13
-116.9
-12.8
-99.05
-32.39
-62.29
-89.12
-60.84
-114.88
-42.75
-73.6
Operating Margin (%)
- -
- -
- -
- -
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
-3
-3
-5
-9
-10
-11
-3
- -
-5
-2
-2
-2
-1
-1
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-1,400
-560
-215.38
-63.3
-116.47
-128.08
-207.81
-103.33
2.09
-244.84
-82.73
-87.77
-137.33
-110.72
-133.33
-61.4
-124.03
Profit Margin (%)
4
1
1
5
7
8
2
- -
- -
- -
- -
- -
-2
-1
-1
-2
-2
Working Capital
- -
1
- -
- -
- -
- -
- -
- -
- -
2
3
2
2
3
2
1
2
LT Debt
4
1
2
6
9
10
3
1
1
-2
-2
-2
-4
-3
-2
-3
-4
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-50.65
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-0.11
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'08
Dec'08
Mar'09
ST Debt
- -
2
- -
LT Borrowings
4
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
5
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'08
Dec'08
Mar'09
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
1
Total Current Liabilities
1
3
3
Payables & Accruals
1
1
3
ST Debt
- -
2
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-38.73%
10%
4.2%
Free Cash Flow
29.83%
16.86%
-38.79%
Net Income, GAAP
-884.88%
-19.7%
-51.03%
Sales/Revenue/Turnover
-19.19%
-17.67%
6.34%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
1
2010
- -
- -
- -
- -
1
2011
- -
- -
- -
- -
1

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
-0.18
- -
- -
- -
-0.08
2010
- -
- -
- -
- -
-0.02
2011
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
Similar Companies
Cambridge Nutritional Sciences plc (CNSL.L)
Truking Technology Limited (300358.SZ)
InfuSystem Holdings, Inc. (INFU)
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS)
AddLife AB (publ) (ADDLF)
iZafe Group AB (publ) (IZAFE-B.ST)
Business
Paradigm Medical Industries, Inc. is dedicated to the creation, production, distribution, and commercialization of sophisticated medical devices aimed at the prompt identification of glaucoma and various other conditions affecting the eye across the United States. The company’s extensive product portfolio encompasses a range of biometric analyzer A-scans, including the P-2000 and P-2500 models, alongside P-2500 A-scan/pachymeters and standalone P2200 pachymeters for precise measurements. They also provide P2700 A/B and P37-II A/B scans for detailed ocular imaging, in addition to advanced blood flow analyzers crucial for detecting and managing glaucoma and other disorders related to retinal vasculature. Visual field testing is supported by their LD 500 and LD700 autoperimeters. Furthermore, the company offers corneal topographers such as the PARAVUE 300 for diagnostic purposes and contact lens fitting, alongside the SURVEYOR 500 for comprehensive cornea and anterior segment analysis. Their diagnostic tools extend to PARAMAX, which assesses ganglion cell functionality to pinpoint potential glaucoma cases, along with P60 and P60 ACI ultrasound biomicroscopes, and the PARACAM 1000, a non-contact endothelial microscope. Complementing these instruments are essential software solutions and accessories. The enterprise was established in 1989 and maintains its operational base in Salt Lake City, Utah.

Company News

APIChat

  • defenseworld.net

    Edap Tms (NASDAQ:EDAP) vs. Paradigm Medical Industries (OTCMKTS:PDMI) Head-To-Head Analysis